The investment community will be closely monitoring the performance of DaVita HealthCare in its forthcoming earnings report. The company is scheduled to release its earnings on August 6, 2024. In that report, analysts expect DaVita HealthCare to post earnings of $2.47 per share. This would mark year-over-year growth of 18.75%. Meanwhile, our latest consensus estimate is calling for revenue of $3.16 billion, up 5.43% from the prior-year quarter. In the context of valuation, DaVita HealthCare is at present tr ...

DaVita (NYSE: DVA) The company's market cap is $12.05 billion, and its stock price was $137 as of the close of markets on July 26, 2024. Notably, in 2024, the stock has rallied over 28% on a year-to-date (YTD) basis. Additionally, DaVita's consistent financial health and strategic expansions into new markets support its growth trajectory. For instance, in the first quarter of 2024, the firm recorded revenue of $3.071 billion, surpassing the estimated $3.028 billion. The net income stood at $240 million, exc ...

In the latest market close, DaVita HealthCare (DVA) reached $139.96, with a +1.46% movement compared to the previous day. The stock exceeded the S&P 500, which registered a gain of 1.08% for the day. At the same time, the Dow added 0.32%, and the tech-heavy Nasdaq gained 1.58%. Investors should also take note of any recent adjustments to analyst estimates for DaVita HealthCare. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Hence, positive alterations in estimat ...

When calling in, please provide the operator the password "Earnings" and provide your name and company affiliation. Investors unable to listen to the conference call will be able to access a replay via our website at investors.davita.com. There will be no telephone replay. This call is also being webcast and can be accessed at the DaVita IR web page. You can join this call as follows: DaVita (NYSE: DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients g ...

Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system. Meanwhile, DVA's PEG ratio is currently 1.04. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. The Medical - Outpatient and Home Healthcare was holding an averag ...

Denver, CO-headquartered DaVita, is a leading provider of dialysis services in the United States to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services, primarily in dialysis centers and contracted hospitals across the country. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease man ...

New York, United States, July 16, 2024 (GLOBE NEWSWIRE) -- As per the Latest Report by Straits Research, the global renal denervation devices market size was valued at USD 54.26 million in 2023. It is estimated to reach an expected value of USD 387 million by 2032, growing at a CAGR of 37.2% during the forecast period (2024–2032). Rising Prevalence of Hypertension Propels the Renal Denervation Devices Market It is anticipated that the number of individuals suffering from hypertension will increase as the gl ...

Shares of the kidney dialysis provider witnessed a loss of 2.97% over the previous month, trailing the performance of the Medical sector with its loss of 1.99% and the S&P 500's gain of 4.34%. For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of $9.62 per share and a revenue of $12.74 billion, representing changes of +13.58% and +4.97%, respectively, from the prior year. Based on our research, we believe these estimate revisions are directly related to near-team stock moves. ...

Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system. Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions. The latest trading session saw DaVita HealthCare (DVA) ending at $142.16, denoting a -0.53% adjustment from its last day's close ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both. Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor. It also includes access to the Zacks Style Scores. What are ...